Loading...

Estrogen–progestin replacement therapy: regulatory action needed

It is now established that the most commonly prescribed estrogen–progestin replacement therapy regimen significantly increases breast cancer risk. What are the risks associated with other regimens? Studies with breast cancer as the outcome cannot answer these questions in the right timeframe. It is...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pike, Malcolm C, Ross, Ronald K
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2002
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC137943/
https://ncbi.nlm.nih.gov/pubmed/12473167
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!